NCT05722496

Difference Between Interval and Continous Intradialytic Exercise on Functional Capacity in Hemodialysis Patient

Interval Versus Continous Intradialytic Training on Muscla Quality Index and Functional Capacity in Hemodialysis Patients
Cairo University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov
Study focus
Disease/Condition
Hemodialysis Complication
Drug/Device/Intervention
Aerobic pedaling exercise
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Cairo University
Location
Cairo, Egypt
Timeline & enrollment
Phase
N/A
Start date
Jan 03, 2023
End date
May 10, 2023
Enrollment
60 participants
Primary outcome

muscle quality index,six minute walk test

Summary

The goal of this study is to find out the effect of interval versus continous intradialytic
 training on muscle quality index and functional capacity in Hemodialysis patients. The main
 question it aims to answer is:
 
 Does interval versus continous intradialytic training have an effect on muscle quality index
 and functional capacity in hemodialysis patients? Patients will be assigned randomly by
 computerized block randomization into two groups:Group (A): 30 patients will participate in 8
 weeks of aerobic exercise in the form of high intensity interval training (HIIT)
 intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30
 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity
 continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per
 week) . primary and secondary variables will be measured before starting treatment and after
 completion (after 2 months )

ICD-10 classifications
Kidney dialysisOther dialysisCare involving dialysisMechanical complication of vascular dialysis catheterHaemoglobinuria due to haemolysis from other external causes
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05722496
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05722496 through Pure Global AI's free database. This phase not specified trial is sponsored by Cairo University and is currently Recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.